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Abstract
Background
The composition of the diet is of increasing importance for the development and maturation
of the ovarian follicles. In Polycystic Ovary Syndrome (PCOS) healthy dietary interventions
improve the clinical spectrum. We hypothesized that dieting and diet inadequacy in the
reproductive life course is associated with impaired programming of ovarian follicles and
contributes to the severity of the PCOS phenotype.
Methods and Findings
To determine associations between the use of a self-initiated diet and diet inadequacy and
the severity of the PCOS phenotype, we performed an explorative nested case control
study embedded in a periconception cohort of 1,251 patients visiting the preconception out-
patient clinic. 218 patients with PCOS and 799 subfertile controls were selected from the
cohort and self-administered questionnaires, anthropometric measurements and blood
samples were obtained. The Preconception Dietary Risk Score (PDR score), based on the
Dutch dietary guidelines, was used to determine diet inadequacy in all women. The PDR
score was negatively associated to cobalamin, serum and red blood cell folate and posi-
tively to tHcy. PCOS patients (19.9%), in particular the hyperandrogenic (HA) phenotype
(22.5%) reported more often the use of a self-initiated diet than controls (13.1%; p = 0.023).
The use of an inadequate diet was also significantly higher in PCOS than in controls (PDR
score 3.7 vs 3.5; p = 0.017) and every point increase was associated with a more than 1.3
fold higher risk of the HA phenotype (adjusted OR 1.351, 95% CI 1.09–1.68). Diet inade-
quacy was independently associated with the anti-Müllerian Hormone (AMH) concentration
(β 0.084; p = 0.044; 95% CI 0.002 to 0.165) and free androgen index (β 0.128; p = 0.013;
95% CI 0.028 to 0.229) in PCOS patients.
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Conclusions
The use of a self-initiated diet and diet inadequacy is associated with PCOS, in particular
with the severe HA phenotype. This novel finding substantiated by the association between
diet inadequacy and AMH needs further investigation.
Introduction
Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder affecting young
women of reproductive age, resulting in subfertility and increased risk of cardiovascular related
disease in later life [1]. The estimated prevalence of PCOS varies between 5–15% [2,3]. PCOS is
characterized by oligo- or anovulation (ovulatory dysfunction; OD), clinical and/or biochemi-
cal signs of hyperandrogenism (HA) and/or polycystic ovaries (Polycystic ovarian morphology;
PCOM), and gene-environment interactions play a significant role in the variability within
PCOS phenotypes [4,5]. The clinical spectrum and severity in PCOS is heterogeneous, includ-
ing reproductive, metabolic and psychological features. Because of the profound cardiovascular
and metabolic disturbances in hyperandrogenic PCOS patients, it is recommended to distin-
guish two subtypes of PCOS according to the severity of disease (HA-PCOS and non HA-P-
COS) [6].
Personal behaviors, such as dieting, smoking, alcohol- and drug use, stress and exercise are
considered behavioral factors that are important for reproductive functioning [7,8]. The com-
position of the preconception diet is of increasing interest, because over- and undernutrition
derange metabolic and endocrine pathways, especially the B-vitamin dependent one-carbon
(1-C) pathway [8–10]. During the development of the germ cells and the maturation of the
ovarian follicles, the methyl groups mainly derived from B vitamins, methionine and choline
are used for DNA synthesis and phospholipid and protein biosynthesis. Deficiencies of these
nutrients are inversely associated with ovarian follicle development, the number of oocytes
retrieved for IVF treatment, embryo quality and pregnancy outcome [8–10]. Worrisome is that
in more than 50% of subfertile couples planning pregnancy the preconception diet is inade-
quate [11]. However it is promising that improvement of the diet can increase the chance of
ongoing pregnancy up to 65% [12]. The prevalence of obesity and PCOS is increasing and
although obesity is not the cause of PCOS it contributes to the clinical spectrum [13]. More-
over, weight loss can improve the clinical spectrum including menstrual regularity, insulin
resistance and quality of life [14] and dietary interventions are therefore part of the clinical
treatment of PCOS.
In the polycystic ovary, an arrest of follicular maturation results in the accumulation of
small antral follicles that produce elevated levels of Anti-Müllerian Hormone (AMH) [15].
AMH concentration is therefore a marker of PCOS severity which is inversely associated with
a healthy diet, irrespective of weight loss [16].
Psychological co-morbidities such as depression, eating and anxiety disorders, which can
affect the nutritional state are also more prevalent in PCOS [17]. Another potential driver for
differences in dieting could be obesity although previous research showed that dieting behavior
is independent of current BMI, but strongly associated with negative emotions and problematic
behaviors [18]. Dietary behavior is acquired during childhood and remains rather stabile over
time only varying during episodes of illnesses, dieting and increased needs [19–22]. Dieting
habits can be transferred unknowingly since the practices mothers adopt predict the children’s
diet quality [23] and because parents contribute to adolescents' motivation to diet [24]. Here
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we hypothesize that regular self-initiated dieting and using an inadequate diet is associated
with alterations in the 1-C pathway and with impaired functioning of ovarian follicles which
contributes to the clinical spectrum of PCOS. We performed a case-cohort study embedded in
a prospective periconception cohort study of couples referred for subfertility, to investigate
whether the use of a self-initiated diet and dietary inadequacy are associated with PCOS sever-
ity and phenotype.
Materials and Methods
Study design
Between October 2007 and March 2011, all couples planning pregnancy and visiting the outpa-
tient clinic of the Department of Obstetrics and Gynaecology at the Erasmus MC, University
Medical Centre Rotterdam, a tertiary hospital in the Netherlands, were offered nutrition and
lifestyle counselling at the preconception outpatient clinic ‘Achieving a Healthy Pregnancy’
[11,12].
In this study women completed a questionnaire from which we extracted general character-
istics, such as age, ethnicity (Dutch or Non-Dutch), educational level (low, intermediate or
high), the use of a diet (energy restricted, vegetarian, macrobiotic, vegan, other) and of six
main food groups (Preconception Dietary Risk score), folic acid supplements (yes/no), vitamin
supplements (yes/no), medication (yes/no), alcohol (yes/no), and smoking (yes/no), physical
exercise (yes/no), and the experience of stress (yes/no). Ethnicity and education level were clas-
sified according to the definition of Statistics Netherlands (www.cbs.nl; 2012). The validated
summary PDR score, based on the Dutch food based dietary guidelines was used to assess diet
inadequacy in the outpatient clinical setting [12,25]. When patients did not meet the dietary
guidelines for the food group, one point was administered. Since six guidelines were evaluated,
the PDR score had a maximum of 6 points and a minimum of 0 points. Thus, the higher the
score the more inadequate the intake according to the guideline. The adequate intake per food
group was defined without a specific time frame by the following guidelines: 4–5 slices of
whole wheat bread daily, the use of monounsaturated or polyunsaturated oils/fats, 200 grams
of vegetables daily, 2 pieces of fruit daily, 3–4 servings of meat weekly and 2 servings of fish
weekly [26]. During the visit at the outpatient clinic the questionnaires were verified by a
trained counsellor.
Subsequently non-fasting blood samples were obtained by venipuncture and anthropo-
metrics (i.e. height, weight and circumferences) were measured. Patients with oligo- or anovu-
lation were screened for ovulatory dysfunction by trained professionals according to a
standardized protocol.
The diagnosis of PCOS was based on the Rotterdam criteria [5] including the presence of
oligo- or anovulation (i.e. menstrual bleeding interval between 35–182 days or absence of men-
strual bleeding for more than 182 days), hyperandrogenism (Ferriman-Gallwey score 9 and/
or a Free Androgen Index> 4.5), and/ or polycystic ovaries (volume exceeding 10 cm3 and/or
the follicle count was 12).
Study population
During the study period 1,348 couples visited the preconception outpatient clinic of which
1,251 participated in the study and provided a written informed consent. Two hundred and
fifty one patients were diagnosed with PCOS and 33 patients were excluded because of an
uncertain diagnosis or the period between enrolment and PCOS diagnosis comprised more
than one year. From the remaining 1,000 patients we excluded patients with an incomplete fer-
tility medical record (n = 80), patients with ovulatory disorders such as imminent ovarian
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failure, WHO 1 or WHO 2 disorders (n = 107) and fertile patients (n = 14) who were referred
because of a complicated obstetrical history. This resulted in a control group of 799 subfertile
patients (Fig 1). According to phenotype, we divided the PCOS group (n = 218) in the HA
(n = 112) and non HA (n = 106) phenotype.
Fig 1. Flowchart of the selection of the study population. IOF = imminent ovarian failure; WHO1 = hypogonadotropic hypogonadal anovulation;
WHO2 = normogonadotropic normoestrogenic anovulation; HA = hyperandrogenic.
doi:10.1371/journal.pone.0142772.g001
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Biomarkers
On the day of the visit at the outpatient clinic blood samples were drawn and processed within
2 hours after withdrawal. Serum was stored at −20°C until assayed. In blood the biomarkers of
1-C metabolism serum and red blood cell (RBC) folate, serum cobalamin, and plasma total
homocysteine (tHcy) were determined in all study participants. tHcy was measured using
HPLC-TandemMS. For the determination of serum folate and cobalamin an immunoelectro-
chemoluminescence assay was used (E170; Roche Diagnostics GmbH, Mannheim, Germany)
and for the determination of RBC folate the ADVIA 120 Hematology Analyzer was used
(Bayer Diagnostics, Leverkusen, Germany).
For clinical purposes the patients with PCOS were additionally screened on hormonal and
metabolic parameters. Testosterone was measured using radioimmunoassay (RIA) (Siemens
DPC, Los Angeles, CA) and glucose levels were measured by using a Hitachi 917 analyzer
(Roche Diagnostics, Almere, The Netherlands). The Free Androgen Index (FAI) was calculated
as follows; 100 x [T (nmol/L) / Sex hormone-binding globulin (SHBG) (nmol/L)]. An immu-
noluminometric assay (Immulite1 platform, Siemens Diagnostic Product Corporation, Los
Angeles, CA) was used to measure LH, FSH, SHBG, androstenedione, insulin and DHEAS.
Serum AMH (Anti-Müllerian Hormone) levels were measured by using an in-house double-
antibody ELISA (GenII; Beckman Coulter) as previously described [27]. Intra- and interassay
coefficients of variation were, respectively,<5% and<15% for LH,<3% and<18% for FSH,
<3% and>5% for T,<8% and>11% for AD,<4% and>5% for SHBG,<9% and>11% for
DHEAS,<5% and>8% for AMH, and<6% and>8% for insulin.
Statistical analyses
Continuous variables are presented as median with interquartile range. Dichotomous and cate-
gorical variables are presented as count and proportions. Chi Square tests with comparison of
column proportions were performed with a Bonferroni correction to compare the distribution
of categorical variables between PCOS phenotypes and subfertile controls. Mann Whitney U
Tests were performed to compare the total group of PCOS with the subfertile controls. Kruskal
Wallis tests with pairwise comparisons adjusted for the number of pairwise tests were per-
formed for comparison of controls, HA-PCOS patients and non HA-PCOS patients. Simple
linear regression analysis were conducted to establish associations between the PDR score and
the biomarkers of 1-C metabolism. To achieve normality a natural log transformation was per-
formed for cobalamin, RBC Folate and tHcy and a square root transformation for serum folate.
Multivariable logistic regression analysis was applied to calculate the risk of PCOS after one
point increase of the PDR score for each phenotype separately with adjustment for the poten-
tial confounders body mass index (BMI), age, educational level, ethnicity, medication use and
vitamin supplement use. These covariates were selected because of the significant association
with the PDR score or when significant differences revealed between PCOS and controls. Mul-
tivariable linear regression analysis were performed to investigate associations between the
PDR score and hormonal parameters in PCOS only with adjustments. Statistical analyses were
performed using SPSS software for Windows (version 21.0, IBM SPSS, Statistics for Windows,
Armonk, NY: IBM Corp). The level of significance was set to 0.05 for all analyses.
Ethical approval
All questionnaire data and materials were processed anonymously. This study was conducted
according to the guidelines of the Declaration of Helsinki, and all procedures involving patients
were approved by the Medical Ethical and Institutional Review Board at the Erasmus MC,
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University Medical Centre in Rotterdam, the Netherlands. Written informed consent was
obtained from all patients.
Results
To evaluate selection bias we present the general characteristics of the included and excluded
patients in S1 Table. The general characteristics were comparable in both groups except the
slightly younger age, higher percentage of smoking and alcohol use and slightly smaller waist
circumference and waist-hip ratio in the study group.
PCOS study population
In Table 1 the general characteristics of PCOS patients (n = 218) and subfertile control patients
(n = 799) are shown. The PCOS group was significantly younger and used less often alcohol,
folic acid and vitamin supplements than subfertile controls, which is validated with the lower
concentrations of serum and RBC folate observed in the PCOS group. They also used more
often a self-initiated diet and were more frequently obese (BMI30).
PCOS phenotypes
In Table 1 we depict the PCOS group divided into the HA (n = 112) and non HA phenotype
(n = 106) and compare the general characteristics with subfertile controls (n = 799). The HA
and non HA phenotype patients were both significantly younger than subfertile controls.
Patients with the HA phenotype exercised less than non HA-PCOS patients and they used less
often alcohol than non HA-PCOS patients or subfertile controls. Patients with the HA pheno-
type were also more likely to use a self-initiated diet and used less often folic acid supplements
than subfertile controls and showed a significantly higher BMI and waist circumference com-
pared to the non HA phenotype and subfertile controls. Moreover, the waist hip ratio, used as
indicator of central obesity, was significantly lower in the non HA phenotype, compared to the
HA phenotype and subfertile controls. Patients with the HA phenotype showed lower levels of
serum and RBC folate than the non HA phenotype and subfertile controls.
Dietary inadequacy assessed with the PDR score
A higher mean PDR score was observed in the PCOS group than in the subfertile controls (3.7
vs 3.5; p = 0.017). Patients with the HA phenotype also showed a higher mean PDR score (3.9;
p<0.001) than the non HA phenotypes (3.5) and the subfertile controls (3.5). The PDR score
per food group was comparable between the groups, except for a higher percentage of inade-
quate meat and fish intake in the HA phenotype (Fig 2).
Table 2 shows that one point increase in the PDR score was associated with a 1.4 fold higher
risk of the HA phenotype (unadjusted OR 1.427, 95% CI 1.183 to 1.721). The PDR score was
inversely associated with age (β -0.037, 95% CI -0.051 to -0.023, p =<0.001), educational level
(category high β -0.311, 95% CI -0.522 to -0.100, p = 0.004) and the use of vitamin supplements
(β -0.192, 95% CI -0.336 to -0.048, p = 0.009) and therefore these covariates were selected for
adjustment of the analyses. Age was a confounder and inversely associated with the severity of
the PCOS phenotype and positively associated with the PDR score. After adjustment in model
1 the risk of the HA phenotype slightly increased (OR 1.520, 95% CI 1.240 to 1.863) and atten-
uated in model 2 (OR 1.351, 95% CI 1.087 to 1.679), but remained significant. The PDR score
was not associated with the risk of the non HA phenotype.
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The PDR score and biomarkers of 1-C metabolism
To investigate the association between dietary inadequacy and the markers of 1-C metabolism,
we subsequently performed linear regression analyses in the PCOS patients and subfertile
Table 1. Preconception general characteristics.
Total PCOS
(n = 218)
(Group A)
HA-PCOS (n = 112)
(Group A1)
non HA-PCOS
(n = 106) (Group A2)
Subfertile controls
(n = 799) (Group B)
P value
(Group A, B)
P value (Group
A1, A2, B)
Age (years) 28.5 (25.5–31.3) 27.7 (24.5–30.0)a 29.0 (27.2–32.2)a 33.1 (29.6–36.4)b <0.01 <0.01
Ethnicity
Dutch 122 (56.0%) 54 (48.2%) 68 (64.2%) 445 (56.0%) 1.00 0.06
Other 96 (44.0%) 58 (51.8%) 38 (35.8%) 350 (44.0%) - -
Educational level
Low 30 (14.6%) 20 (18.7%) 10 (10.1%) 120 (15.8%) 0.75 0.09
Intermediate 97 (47.1%) 55 (51.4%) 42 (42.4%) 336 (44.2%) - -
High 79 (38.3%) 32 (29.9%) 47 (47.5%) 304 (40.0%) - -
Lifestyle
Parameters:
Diet (Yes) 43 (19.9%) 25 (22.5%)b 18 (17.1%)a, b 105 (13.1%)a 0.01 0.02
PDR score (mean; sd) 3.7 (1.14) 3.9 (1.12)a 3.5 (1.13)b 3.5 (1.13)b 0.02 <0.01
Folic acid supplement
use (No)
92 (42.4%) 55 (49.1%)b 37 (35.2%)a, b 268 (33.5%)a 0.02 <0.01
Vitamin supplement
use (No)
145 (67.4%) 78 (70.3%) 67 (64.4%) 471 (59.5%) 0.03 0.07
Medication use (Yes) 75 (34.6%) 41 (36.6%) 34 (32.4%) 255 (32.0%) 0.48 0.63
Alcohol (Yes) 101 (46.3%) 39 (34.8%)b 62 (58.5%)a 439 (54.9%)a 0.02 <0.01
Smoking (Yes) 51 (23.5%) 29 (26.1%) 22 (20.8%) 175 (22.3%) 0.70 0.59
Physical exercise (No) 98 (51.0%) 56 (60.2%)a 42 (42.4%)b 366 (49.4%)a, b 0.68 0.04
Stress (Yes) 64 (34.4%) 30 (33.7%) 34 (35.1%) 245 (33.6%) 0.83 0.96
Measurements:
BMI (kg/m2) 25.6 (22.0–31.2) 29.2 (24.9–33.2)a 23.1 (20.6–26.6)b 24.5 (22.0–28.3)c 0.03 <0.01
BMI categories:
<20 21 (9.6%) 3 (2.7%)a 18 (17.0%)b 54 (6.8%)a <0.01 <0.01
20 <25 82 (37.6%) 27 (24.1%)b 55 (51.9%)a 373 (47.0%)a - -
25 <30 52 (23.9%) 31 (27.7%)a 21 (19.8%)a 228 (28.8%)a - -
30 63 (28.9%) 51 (45.5%)b 12 (11.3%)a 138 (17.4%)a - -
Waist circumference
(cm)
85 (74–97) 93 (83–105)a 77 (71–89)b 84 (75–93)c 0.28 <0.01
Waist hip ratio 0.81 (0.75–0.87) 0.84 (0.80–0.91)a 0.78 (0.74–0.83)b 0.81 (0.75–0.87)c 0.66 <0.01
Biochemical
Parameters:
Cobalamin (pmol/L) 305 (232–392) 282 (215–371) 322 (254–416) 310 (237–411) 0.51 0.09
RBC Folate (nmol/L) 960 (769–1182) 861 (718–1067)a 1059 (869–1380)b 1037 (831–1328)b <0.01 <0.01
Folate (nmol/L) 25.1 (15.6–36.1) 21.3 (13.4–30.9)a 29.1 (17.8–43.4)b 30.1 (19.0–41.3)b <0.01 <0.01
tHcy (μmol/L) 8.8 (7.4–10.2) 8.5 (7.3–10.2) 9.1 (7.7–10.2) 8.4 (7.1–9.9) 0.08 0.12
Note: Values are expressed as median (interquartile range) or number (%). HA = Hyperandrogenic; PDR score = Preconception Dietary Risk score;
BMI = Body Mass Index; RBC Folate = Red Blood Cell Folate; tHcy = homocysteine. Normal range biochemical parameters; Folate 8 nmol/L, RBC folate
500 nmol/L, Cobalamin 145 pmol/L, tHcy <15 μmol/L. For pairwise comparisons; each subscript letter denotes a subset of categories whose column
proportions do not differ signiﬁcantly from each other.
doi:10.1371/journal.pone.0142772.t001
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controls with the separate biomarkers cobalamin, RBC folate, serum folate and tHcy. A nega-
tive linear association was established between the PDR score and cobalamin (unadjusted β
-0.052; p< 0.001; 95% CI -0.074 to -0.030), RBC folate (unadjusted β -0.045; p< 0.001; 95%
CI -0.067 to -0.023) and serum folate (unadjusted β -0.193; p< 0.001; 95% CI -0.295 to
-0.091). A positive linear association was observed between the PDR score and tHcy (unad-
justed β 0.030; p< 0.001; 95% CI 0.014 to 0.045). Additional adjustment for age, BMI, ethnic-
ity, education, vitamin supplement use and medication use slightly attenuated the effect
estimates of the four biomarkers and remained significant.
Fig 2. The items of the Preconception Dietary risk score.Depicted are the percentages of inadequate dietary intake for each food group. Meat* and
fish** intake differed significantly between the controls, HA and non HA phenotype (respectively p 0.006 and p 0.039).
doi:10.1371/journal.pone.0142772.g002
Table 2. Multivariable logistic regression analyses; The risk of PCOS after one point increase in the Preconception Dietary Risk score compared
to subfertile controls.
HA-PCOS non HA-PCOS
OR P
value
95% CI OR P
value
95% CI
Unadjusted: 1.427 0.000 1.183–
1.721
0.978 0.805 0.817–
1.170
Model I: Adjusted for BMI, ethnicity, education, vitamin supplement use and medication
use
1.520 0.000 1.240–
1.863
0.937 0.520 0.767–
1.143
Model II: Adjusted for age, BMI, ethnicity, education, vitamin supplement use and
medication use
1.351 0.007 1.087–
1.679
0.866 0.176 0.703–
1.067
HA = Hyperandrogenic; OR = Odds Ratio; CI = Conﬁdence Interval; BMI = Body Mass Index.
doi:10.1371/journal.pone.0142772.t002
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Diet and hormonal and metabolic parameters in PCOS patients
In Table 3 the serum characteristics of the PCOS phenotypes are depicted. The PDR score was
positively associated with AMH and FAI. A positive linear association was established between
the PDR score and AMH (unadjusted β 0.084; p = 0.044; 95% CI 0.002 to 0.165), however after
adjustment for age and BMI this association was no longer significant.
This association was stronger when repeated only in the HA+OD+PCOM and OD+PCOM
PCOS patients (unadjusted β 0.109; p = 0.011, 95% CI 0.025 to 0.193) and remained significant
after adjustment for age (β 0.100; p = 0.022, 95% CI 0.015 to 0.185) and BMI (β 0.102;
p = 0.018, 95% CI 0.018 to 0.186).
The PDR score was also positively associated with FAI (unadjusted β 0.128; p = 0.013; 95%
CI 0.028 to 0.229), but lost significance after adjustment for age and BMI.
Discussion
This explorative study demonstrates that patients with PCOS more often use a self-initiated
diet and an inadequate diet than subfertile controls. This is substantiated by the use of a more
inadequate diet in patients with the more severe HA phenotype and the positive association
between diet inadequacy and the AMH concentration in PCOS patients.
Table 3. Serum characteristics according to PCOS phenotype.
HA-PCOS (n = 112) non HA-PCOS (n = 106)
Hormonal Parameters:
AMH (μg/L) 10.3 (6.7–14.8) 7.6 (4.8–11.2)**
FSH (U/l) 6.1 (5.2–7.2) 5.9 (3.9–7.8)
LH (U/l) 9.8 (6.7–14.6) 6.6 (4.4–11.7)**
Progesterone (nmol/l) 1.2 (0.9–1.9) 1.5 (0.9–10.2)*
17- hydroxyprogesterone (nmol/l) 2.9 (2.2–4.4) 2.7 (1.9–5.8)
Estradiol (pmol/L) 225.5 (181.0–300.5) 234.0 (143.0–363.0)
SHBG (nmol/l) 27.0 (21.4–39.7) 56.4 (45.3–81.6)**
Testosterone (nmol/l) 2.0 (1.6–2.8) 1.2 (0.9–1.6)**
FAI 7.0 (5.5–10.7) 2.2 (1.4–3.0)**
Androstenedione (nmol/l) 11.8 (9.7–17.4) 8.6 (6.4–10.4)**
DHEAS(μmol/L) 5.7 (3.9–7.4) 4.8 (3.3–6.1)**
Metabolic Parameters:
Insulin (pmol/l) 67.0 (40.0–118.0) 34.0 (17.0–57.0)**
Glucose (mmol/l) 4.9 (4.6–5.3) 4.7 (4.5–5.0)**
TG (mmol/L) 1.0 (0.8–1.6) 0.9 (0.7–1.2)*
Total–C (nmol/L) 5.4 (4.6–6.7) 5.2 (4.5–6.7)
HDL-C (nmol/L) 1.4 (1.1–1.8) 1.7 (1.4–2.2)**
LDL-C (nmol/L) 3.8 (3.1–4.6) 3.4 (2.8–4.4)*
Apolipoprotein A1 209.6 (183.3–256.7) 239.4 (198.0–281.8)**
Apolipoprotein B 124.1 (103.6–148.8) 115.2 (84.1–136.1)**
Note: Values are expressed as median (interquartile range)
* = p <0.05
** = p <0.01.
HA = Hyperandrogenic; FSH = Follicle Stimulating Hormone; LH = Luteinizing Hormone; SHBG = Sex Hormone Binding Globulin; FAI = Free Androgen
Index; DHEAS = dehydroepiandrosterone sulfate; TG = Triglycerides; Total-C = total Cholesterol; HDL-C = HDL-cholesterol; LDL-C = LDL-cholesterol.
Mann Whitney U Tests were performed.
doi:10.1371/journal.pone.0142772.t003
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The strength of the study is the large sample size and case-cohort design to reduce selection
and information bias. Furthermore, standardized anthropometric measurements were per-
formed by trained counsellors who verified all questionnaire data individually during the pre-
conception visit at the outpatient clinic. Several adjustments were made including BMI to
minimize the presence of underreporting and overreporting of dietary intake. The PDR score
was previously validated in the same study population and is shown to be a sensitive and sim-
ple tool to assess diet inadequacy [25]. Another strength of the study is that biomarkers were
measured to validate the PDR score and that all laboratory determinations were measured in
the same hospital. The PDR score estimates dietary inadequacy and not unhealthy overcon-
sumption which is a limitation [25]. We are aware that although the PDR score covers the six
main food groups, it does not reflect the total nutrient and energy intake. The control group
consisted of patients referred for subfertility which reduces the external validity of the study.
We were able to use clinical and laboratory data for PCOS diagnosis, which were not available
for subfertile controls.
Despite numerous efforts, genetic research does not elucidate the developmental origin of
PCOS. We suggest that this can be due to a more significant role of gene-nutrient interactions
affecting epigenetic mechanisms of multiple pathways regulating ovarian function during the
course of life. Previous research demonstrated that genes are prenatally programmed by andro-
gen exposure in utero, resulting in disturbed ovarian and adrenal steroidogenesis [28],
impaired oocyte development [29] and PCOM [30]. The diet is important in epigenetics by
supplying substrates and methyl groups that are important for gene methylation, programming
and subsequent expression and silencing of the genome. Dietary inadequacies can therefore
lead amongst other pathways to derangements in the 1-C pathway, resulting in hypomethyla-
tion and altered gene expression [8,31]. As a first hit the nutritional environment in-utero can
affect reproductive function in the offspring through impaired gonadal organogenesis before
birth [31–33]. In rabbits, Leveille et al showed prenatal and postnatal effects of the diet on ovar-
ian function and morphology by the number of atretic follicles [34]. Not only during early life
but also postnatally through puberty and adolescence, diet can affect gene expression as second
or third hit influencing disease occurrence and severity. Adolescents suffering from overweight
and psychological problems are at risk to develop nutritional inadequacies [17,35]. Therefore
these data support our hypothesis that the use of a self-initiated diet and dietary inadequacies
can contribute to a clinical heterogeneous spectrum of PCOS phenotype development.
This study showed an association between the use of a more inadequate diet in PCOS
patients and disease severity which is further underlined by a lower serum and RBC folate.
Homocysteine concentrations were higher as well, although this did not reach statistical signifi-
cance. The study of Rodrigues et al supports this finding showing a poor diet quality in PCOS
patients (56% inadequacy according to the Brazilian healthy eating index) [36]. Studies com-
paring diet quality in PCOS to controls are contradictory. Comparable dietary compositions in
PCOS and controls are reported [37–39], whereas the group of Moran et al observed a higher
diet quality in PCOS [40]. A high prevalence of folate deficiency and increased levels of homo-
cysteine is previously observed in PCOS substantiating our results and the association with the
involvement of the one carbon pathway [41,42]. An explanation for the different findings in
other studies is that in all other studies the assessment of diet inadequacy was performed
always after diagnosing PCOS. Moreover, due to the exclusion of dieting, non-stabled weighted
or normal weighted PCOS patients in other studies, selection bias could explain the different
results. Information bias due to the awareness of PCOS and the intention to treat can also
explain the differences with other studies. Finally, in contrast to other studies, we also investi-
gated the association with the severity of the PCOS phenotypes and compared them with sub-
fertile controls.
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Our results are in line with studies showing the importance of dietary treatment in PCOS
for reproductive and metabolic outcome [16,43,44]. Furthermore, in overweighed PCOS
patients it is observed that folate supplement use had beneficial effects on metabolic profiles
[45], which indicates the involvement of the 1-C cofactor folate in PCOS.
The positive linear association between the PDR score and AMH concentration, and PCOS
severity very much supports the function of AMH as marker of the spectrum [46]. This is sup-
ported by Nybacka et al showing a decrease in AMH in PCOS patients following a 4 month cal-
orie restricted, well-balanced diet [16]. Another observation is that PCOS gradually disappears
during ageing [47,48]. We suggest that the known improvement of the diet during the course
of life also contributes to its disappearance which is supported by the gradual decrease of AMH
during ageing [49]. FAI as marker for androgen excess was also positively associated with diet
inadequacy, which is in line with the findings of others. [43]. According to the biological gradi-
ent criteria of Hill, the associations of AMH and FAI with the PDR score strengthen the rela-
tionship between diet inadequacy and PCOS severity. This is substantiated by a stronger linear
association between the PDR score and AMH after exclusion of the subpopulation without
PCOM (HA+OD) or without OD (HA+PCOM). After adjustment for age and BMI this associ-
ation remained significant, demonstrating the heterogeneity of the hyperandrogenic
phenotype.
To conclude, this explorative study shows for the first time that the use of a self-initiated
diet and diet inadequacy are associated with PCOS as well as PCOS phenotype. These findings
emphasize the need for prospective research from the reproductive life course onwards with a
focus on the role of the inadequacy of the diet in the developmental origins of PCOS. More-
over, in PCOS treatment more attention should be given to the adherence of an adequate diet.
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